Skip to main content
Peter MacCallum Cancer Centre
  • Donate
  • Location
  • Search
  • English
  • Easy English
  • العَرَبِيَّة Arabic
  • 中文 Chinese
  • Eλληνικά Greek
  • हिन्दी Hindi
  • Italiano Italian
  • Tagalog Tagalog
  • Türkçe Turkish
  • Tiếng Việt Vietnamese
  • About
  • Profiles
  • Careers
  • Education
  • News
  • Events
  • Get involved
  • Contact
  • Cancer types
    • Breast
    • Upper Gastrointestinal
    • Lower Gastrointestinal
    • Genitourinary Oncology
    • Gynae-oncology
    • Clinical Haematology
    • Head & neck
    • Lung
    • Melanoma & Skin
    • Neuro-oncology
    • Paediatric
    • Sarcoma
    • Cancer of unknown primary
  • Our services
    • Diagnosis & investigations
    • Treatment
    • Support services
    • Cancer information & resources
  • Coming to Peter Mac
    • Melbourne
    • Bendigo
    • Box Hill
    • Moorabbin
    • Sunshine
    • Telehealth
  • Research & discovery
    • Clinical research
    • Research laboratories
    • CoE Cellular Immunotherapy
    • Core facilities
    • ProsTIC
    • Research cohort studies
    • Research programs
    • Doing research with us
    • Commercialisation, partnerships and industry engagement
    • Publications
    • Research strategy
    • Education in research
    • Biomedical Animation
    • National Particle Therapy Symposium
    • Use your cancer experience to help guide research
  • Clinical Trial Care
    • Patients and Families
    • Health Professionals
    • Clinical Trial Sponsors
  1. Home
  2. Profiles
  3. Prof Mark Dawson
Consultant Haematologist; Head: Translational Haematology Program; Group Leader, Senior Faculty

Prof Mark Dawson

Biography

Professor Dawson is a clinician-scientist at the Peter MacCallum Cancer Centre. He is the program head of the Translational Haematology Program, Group leader of the Cancer Epigenetics Laboratory and Consultant Haematologist in the Department of Haematology. His research interest is studying epigenetic regulation in normal and malignant haematopoiesis. He is a fellow of the Royal Australasian College of Physicians and Royal College of Pathologists of Australasia. After completing his clinical training in Melbourne, Australia he was awarded the prestigious General Sir John Monash Fellowship and Cambridge Commonwealth Trust Fellowship, which he used to complete his PhD at the University of Cambridge. During his PhD, he described one of the first examples of how a signaling kinase can directly influence transcription by acting as a histone-modifying enzyme. Following his PhD, he was the top ranked applicant for a career development fellowship in the UK and was awarded the inaugural Wellcome Trust Beit Prize Fellowship to pursue his research into epigenetic regulation of leukaemia stem cells. This research identified a new therapeutic strategy for acute myeloid leukaemia by targeting the BET bromodomain proteins that function as epigenetic readers. This work helped set the platform for clinical trials with this first in class epigenetic therapy. His research has been published in world leading journals including Nature, Cell, Science and New England Journal of Medicine. He is currently a Professor in the Sir Peter MacCallum Department of Oncology and Centre of Cancer Research at the University of Melbourne. He is currently the Senior Research Fellow for the Leukaemia Foundation of Australia and a Howard Hughes Medical Institute International Research Scholar.

Related Links

Haematology
Acute Leukemia and Myelodysplasia
Mark Dawson Laboratory

News

New insight into most common type of infant leukaemia
Double discovery boosts global quest leukaemia cures

Awards

2017-2022: Howard Hughes Medical Institute International Research Scholar

2014-2018: Senior Fellow, Leukaemia Foundation Australia.

2014-2017: VESKI Innovation Fellow.

2014-2015: Herman Clinical Fellow, University of Melbourne.

2010-2014: Wellcome Trust - Beit Career Development Fellow

2006-09: General Sir John Monash Scholar

2006-09: Cambridge Commonwealth Trust Fellow

2006-09: Raymond and Beverly Sackler Fellow, University of Cambridge

2006: HSANZ - Haematology and Oncology Targeted Therapies Award

2006: HSANZ Young Investigator Award

Qualifications

MBBS (Hons), BMedSci, FRACP, FRCPA, PhD (Cantb)
Mark Dawson's complete list of publications

Consultant Haematologist; Head: Translational Haematology Program; Group Leader, Senior Faculty

Prof Mark Dawson

Peter MacCallum Cancer Centre

  • Victorian Comprehensive Cancer Centre building
    305 Grattan Street
    Melbourne VIC 3000
    Australia
    Peter MacCallum Cancer Centre
  • (03) 8559 5000 (In an emergency, call 000)
  • (03) 8559 7379 (Main fax)
  • (03) 8559 7371 (Referrals fax)
  • Locations
    • Melbourne
    • Bendigo
    • Box Hill
    • Moorabbin
    • Sunshine
  • About us
    • Get involved
    • Upcoming events
    • Partnerships
    • Patient charter
  • Cancer types
  • Cancer services
    • Diagnosis & investigations
    • Treatments
    • Cancer info & resources
  • Refer your patient
  • Peter MacCallum Cancer Foundation
  • Australian Cancer Survivorship Centre
  • Research & discovery
    • Clinical research & trials
    • Research cohort studies
    • Research labs
  • Careers
  • Education

Our Community

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Contact us
Comments & feedback

The Peter MacCallum Cancer Centre acknowledges the traditional owners of the land on which our five sites are located throughout Victoria. We recognise their strength and resilience and pay our respects to their Elders past and present.

Languages
Auslan
Interpreter
Site by Icon Agency
  • Privacy policy
  • Terms & Conditions
  • Intranet